Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at the alternatives available when South Korea does not acknowledge safeguards for missing deadlines as provided in the WIPO’s Patent Cooperation Treaty rules -
Sponsored by Spoor & FisherMargaret Le Galle of Spoor & Fisher explains why the Plant Variety Protection Act 2021 will bring Nigerian IP law in line with international norms
-
Sponsored by Cabinet Beau de LoménieFrancis Declercq of Cabinet Beau de Loménie looks at the key tax changes arising from the IP box regime in France
-
Sponsored by RNA, Technology and IP AttorneysRachna Bakhru of RNA Technology and IP Attorneys explains the urgent need for clear regulations surrounding cryptocurrencies and NFTs in India
-
Sponsored by Remfry & SagarCA Brijesh and Shubham Shende of Remfry & Sagar describe why the Indian courts seem to be taking a more lenient view of comparative advertising
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains the patent eligibility of AI-related inventions in Japan
